Performance and economic evaluation of the molecular detection of pathogens for patients with severe infections: the EVAMICA open-label, cluster-randomised, interventional crossover trial. [electronic resource]
Producer: 20180711Description: 1613-1625 p. digitalISSN:- 1432-1238
- Aged
- Anti-Bacterial Agents -- therapeutic use
- Cost-Benefit Analysis
- Cross-Over Studies
- Endocarditis -- blood
- Febrile Neutropenia -- blood
- Female
- Hospital Mortality
- Humans
- Intensive Care Units -- statistics & numerical data
- Intention to Treat Analysis
- Male
- Middle Aged
- Molecular Diagnostic Techniques -- economics
- Quality Improvement
- Retrospective Studies
- Risk Factors
- Sepsis -- blood
- Time Factors
- Time-to-Treatment -- economics
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.